Stem cell combo shows promise for Parkinson's in small trial

This study tested whether a combination of platelet-rich plasma (PRP) and stem cell therapy could help people with Parkinson's disease. Thirty patients aged 30–50 received three PRP injections over three months, followed by a booster dose after one year. Researchers measured changes in movement, mood, and quality of life using standard Parkinson's rating scales. The goal was to see if this regenerative medicine approach could ease symptoms, not cure the disease.